Background and objective: The aim was to compare the effects of two different priming doses and priming intervals with the standard intubating dose of rocuronium on the onset time and intubation conditions.Methods: After induction of anaesthesia, 75 patients were randomly assigned to one of five groups. Patients in Group 1 received a priming dose of rocuronium 0.06 mg kg−1 followed 2 min later by rocuronium 0.54 mg kg−1, Group 2 received a priming dose of 0.10 mg kg−1 followed 2 min later by a rocuronium injection of 0.50 mg kg−1. Group 3 was given a priming dose of 0.06 mg kg−1 followed 3 min later by administration 0.54 mg kg−1, where Group 4 received a priming dose of 0.10 mg kg−1 followed 3 min later by injection of 0.50 mg kg−1. Group 5 received a placebo injection followed 3 min later by rocuronium 0.60 mg kg−1.Results: Priming with a 3 min priming interval shortened the onset time of rocuronium irrespective of the dosage of (P < 0.001). Clinical duration of action was significantly longer after priming in Group 4 than in Group 5. Clinically acceptable intubation conditions were obtained in all patients.Conclusions: Priming with a 3 min priming interval was effective when rapid tracheal intubation with rocuronium was necessary. However, priming with rocuronium should be used carefully with special attention given to the possibility of hypoxia and aspiration of gastric contents in awake patients.
Background: Sleep disturbances are common in intensive care units (ICUs) and negatively impact patient outcomes. Understanding differences in sleep quality and disrupting factors between patients receiving mechanical ventilation (MV) and spontaneously breathing patients (SBP) is essential for improving ICU care. Aim: To compare sleep quality and sleep‐disrupting factors between patients receiving MV and SBP during their ICU stay. Study Design: This observational study was conducted in a 16‐bed ICU in Türkiye. A total of 186 ICU patients (62 receiving MV and 124 SBP) were included. Sleep quality and disrupting factors were assessed using the Modified Freedman Sleep Quality Questionnaire (mFSQQ) and Richards‐Campbell Sleep Questionnaire (RCSQ) at 24‐h admission (T0) and pre‐discharge (T1). Results: Sleep quality scores were significantly lower in patients receiving MV than in SBP ( p < 0.05). At T0, patients receiving MV experienced greater sleep disruptions due to pain and vital sign monitoring, while SBP had more disturbances from nursing interventions, medication administration and alarms ( p < 0.05). By T1, sleep disturbances from pain, medical interventions and diagnostic procedures had significantly decreased in both groups ( p < 0.05); however, environmental factors such as noise, lighting and staff conversations remained major disruptors. Repeated measures analysis showed a significant time effect for sleep disruptions from pain, nursing interventions, vital sign monitoring and medication administration ( p < 0.001), while no time effect was found for noise, light or staff conversations. Conclusion: Although patients receiving MV had lower sleep quality, ICU environmental factors were a major source of sleep fragmentation for all patients. These findings emphasise the need for ICU‐wide and targeted interventions to optimise sleep quality. Relevance to Clinical Practice: Implementing tailored sleep protocols and optimising ICU care can reduce sleep disruptions, enhance patient comfort and improve recovery by addressing both patient‐specific and environmental factors.
1 April 2020 in Uludağ Üniversitesi Tıp Fakültesi Dergisi
Deliryum; akut başlangıçlı, mental durumda dalgalanmalar gösteren ve geri dönüşü olan bir sendromdur. Hastaneye başvuran hastaların %10-30'unda deliryum geliştiği tahmin edilmektedir. Deliryum; yaşlı, operasyon sonrası ve yoğun bakım hasta popülasyonların da sıklıkla görülmektedir. Deliryum sonucunda gelişen, uzamış hastane yatış süresi, artmış morbidite, hastane maliyeti ve mortalitenin önüne geçilmesi için ve deliryum semptomlarının erken dönem kontrol altına alınabilmesi için deliryumun erken tanısı önem kazanmaktadır. Bu durum deliryuma özel tasarlanmış veya tanılanmasına yardımcı araçlardan yararlanmak, bu araçların amaç ve işlevini bilmek konusunu gündeme getirmektedir. Deliryumu önlemek, tespit etmek, etkili stratejiler belirlemek ve uygulamak adına ilk adım, uygun değerlendirme aracı ile hastaları izlemektir. Sağlık profesyonellerinin çoğu deliryumu göz ardı edebilmekte veya yönetmede zorlanabilmektedir. Bu derleme makalesinde deliryum değerlendirilmesinde sık kullanılan ölçme araçlarının amaç, işlevi ve uygunluğu özetlenerek sağlık profesyonellerine yol göstermesi ve literatürde konu ile ilgili eksikliğin giderilerek farkındalık oluşturması amaçlanmaktadır.
29 January 2021 in Turkish Journal of Internal Medicine
Introduction: This study aims to evaluate presenting symptoms, clinical and laboratory findings, and treatment modalities of adult patients presenting with mushroom poisoning treated in the intensive care unit (ICU) with special consideration of extracorporeal liver support systems. Materials and methods: Records of patients with mushroom poisoning treated in the ICU between January 2007 and December 2014 were analyzed retrospectively. Results: Sixteen adult patients were treated in the ICU for mushroom poisoning during the designated study period. Presentation to the hospital was most common during October of each year. Average time from ingestion of mushrooms to first symptoms was 17.81 hours, and to ICU admission was 2.38 days. The most common symptoms were nausea, vomiting and diarrhea. The most common laboratory finding was elevation of liver transaminases. In cases with elevated liver transaminases, penicillin G, silibinin and N-acetyl cysteine were used. Extracorporeal support systems were used in 9 cases. Two cases underwent emergency liver transplantation. Conclusion: Liver transplantation is the most definitive and effective treatment in indicated cases of mushroom poisoning. Extracorporeal support systems should be considered in the early period both as a treatmet modality on their own or to save time until the definitive treatment is possible. The question of which extracorporeal detoxification technique to use is difficult to answer and controlled clinical trials which compare their efficacy are needed.
1 January 2023 in Revista da Associação Médica Brasileira
The aim of this study was to evaluate the combination treatments with intravenous fosfomycin for carbapenem-resistant Klebsiella pneumoniae infections in a tertiary-care center.